HEADER TRANSFERASE 06-JUN-14 4TOS TITLE CRYSTAL STRUCTURE OF TANKYRASE 1 WITH 355 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TANKYRASE-1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 1105-1315; COMPND 5 SYNONYM: TANK1,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 5,ARTD5, COMPND 6 POLY [ADP-RIBOSE] POLYMERASE 5A,TNKS-1,TRF1-INTERACTING ANKYRIN- COMPND 7 RELATED ADP-RIBOSE POLYMERASE,TANKYRASE I; COMPND 8 EC: 2.4.2.30; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.CHEN,X.ZHANG,L.LUM,C.CHEN REVDAT 5 27-DEC-23 4TOS 1 REMARK REVDAT 4 25-DEC-19 4TOS 1 REMARK REVDAT 3 20-SEP-17 4TOS 1 SOURCE JRNL REMARK REVDAT 2 01-JUL-15 4TOS 1 JRNL REVDAT 1 20-MAY-15 4TOS 0 JRNL AUTH O.KULAK,H.CHEN,B.HOLOHAN,X.WU,H.HE,D.BOREK,Z.OTWINOWSKI, JRNL AUTH 2 K.YAMAGUCHI,L.A.GAROFALO,Z.MA,W.WRIGHT,C.CHEN,J.W.SHAY, JRNL AUTH 3 X.ZHANG,L.LUM JRNL TITL DISRUPTION OF WNT/ BETA-CATENIN SIGNALING AND TELOMERIC JRNL TITL 2 SHORTENING ARE INEXTRICABLE CONSEQUENCES OF TANKYRASE JRNL TITL 3 INHIBITION IN HUMAN CELLS. JRNL REF MOL.CELL.BIOL. V. 35 2425 2015 JRNL REFN ESSN 1098-5549 JRNL PMID 25939383 JRNL DOI 10.1128/MCB.00392-15 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.2_1309) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 41783 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 2087 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.0481 - 4.4412 0.99 2821 149 0.1827 0.1739 REMARK 3 2 4.4412 - 3.5267 1.00 2723 144 0.1524 0.1912 REMARK 3 3 3.5267 - 3.0814 1.00 2707 142 0.1691 0.1970 REMARK 3 4 3.0814 - 2.7998 1.00 2666 140 0.1900 0.2322 REMARK 3 5 2.7998 - 2.5993 1.00 2682 140 0.1869 0.2314 REMARK 3 6 2.5993 - 2.4461 1.00 2667 141 0.1874 0.2553 REMARK 3 7 2.4461 - 2.3236 1.00 2644 138 0.1933 0.2706 REMARK 3 8 2.3236 - 2.2225 1.00 2647 139 0.1897 0.2404 REMARK 3 9 2.2225 - 2.1370 1.00 2630 139 0.1816 0.2241 REMARK 3 10 2.1370 - 2.0632 1.00 2627 139 0.1884 0.2529 REMARK 3 11 2.0632 - 1.9987 1.00 2605 138 0.1966 0.2042 REMARK 3 12 1.9987 - 1.9416 1.00 2652 139 0.2035 0.2432 REMARK 3 13 1.9416 - 1.8905 1.00 2603 139 0.2267 0.2503 REMARK 3 14 1.8905 - 1.8444 0.99 2603 137 0.2396 0.2896 REMARK 3 15 1.8444 - 1.8020 0.92 2419 123 0.2936 0.3113 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.760 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3389 REMARK 3 ANGLE : 1.013 4563 REMARK 3 CHIRALITY : 0.076 456 REMARK 3 PLANARITY : 0.005 598 REMARK 3 DIHEDRAL : 13.965 1250 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): -8.4964 16.7378 -10.4079 REMARK 3 T TENSOR REMARK 3 T11: 0.2191 T22: 0.2465 REMARK 3 T33: 0.2129 T12: 0.0201 REMARK 3 T13: 0.0251 T23: 0.0029 REMARK 3 L TENSOR REMARK 3 L11: 1.1802 L22: 4.2028 REMARK 3 L33: 1.2556 L12: 0.6148 REMARK 3 L13: -0.1982 L23: -0.2348 REMARK 3 S TENSOR REMARK 3 S11: -0.0667 S12: -0.0765 S13: -0.0991 REMARK 3 S21: 0.1448 S22: -0.0625 S23: 0.0532 REMARK 3 S31: 0.0896 S32: -0.0193 S33: 0.1154 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): -16.8070 52.4902 -18.3409 REMARK 3 T TENSOR REMARK 3 T11: 0.2885 T22: 0.2944 REMARK 3 T33: 0.3718 T12: 0.0051 REMARK 3 T13: -0.0605 T23: 0.0044 REMARK 3 L TENSOR REMARK 3 L11: 2.1768 L22: 5.7666 REMARK 3 L33: 1.3552 L12: -1.6930 REMARK 3 L13: -0.3252 L23: -0.1030 REMARK 3 S TENSOR REMARK 3 S11: 0.1009 S12: 0.0241 S13: -0.1977 REMARK 3 S21: -0.1652 S22: -0.0790 S23: 0.9268 REMARK 3 S31: -0.0115 S32: -0.2816 S33: 0.0013 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4TOS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000201959. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-FEB-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792372 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41931 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 31.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 38.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: HKL-3000 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS PH7.5, 0.2M SODIUM ACETATE, REMARK 280 30% PEG4000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.09750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.07750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.58400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.07750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.09750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.58400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1080 REMARK 465 GLY A 1081 REMARK 465 SER A 1082 REMARK 465 SER A 1083 REMARK 465 HIS A 1084 REMARK 465 HIS A 1085 REMARK 465 HIS A 1086 REMARK 465 HIS A 1087 REMARK 465 HIS A 1088 REMARK 465 HIS A 1089 REMARK 465 SER A 1090 REMARK 465 SER A 1091 REMARK 465 GLY A 1092 REMARK 465 LEU A 1093 REMARK 465 GLU A 1094 REMARK 465 VAL A 1095 REMARK 465 LEU A 1096 REMARK 465 PHE A 1097 REMARK 465 GLN A 1098 REMARK 465 GLY A 1099 REMARK 465 PRO A 1100 REMARK 465 HIS A 1101 REMARK 465 MET A 1102 REMARK 465 ALA A 1103 REMARK 465 PHE A 1208 REMARK 465 GLY A 1209 REMARK 465 GLU A 1314 REMARK 465 ALA A 1315 REMARK 465 MET B 1080 REMARK 465 GLY B 1081 REMARK 465 SER B 1082 REMARK 465 SER B 1083 REMARK 465 HIS B 1084 REMARK 465 HIS B 1085 REMARK 465 HIS B 1086 REMARK 465 HIS B 1087 REMARK 465 HIS B 1088 REMARK 465 HIS B 1089 REMARK 465 SER B 1090 REMARK 465 SER B 1091 REMARK 465 GLY B 1092 REMARK 465 LEU B 1093 REMARK 465 GLU B 1094 REMARK 465 VAL B 1095 REMARK 465 LEU B 1096 REMARK 465 PHE B 1097 REMARK 465 GLN B 1098 REMARK 465 GLY B 1099 REMARK 465 PRO B 1100 REMARK 465 HIS B 1101 REMARK 465 MET B 1102 REMARK 465 ALA B 1103 REMARK 465 GLY B 1205 REMARK 465 GLY B 1206 REMARK 465 MET B 1207 REMARK 465 PHE B 1208 REMARK 465 GLY B 1209 REMARK 465 VAL B 1284 REMARK 465 ASN B 1285 REMARK 465 GLY B 1286 REMARK 465 LEU B 1287 REMARK 465 ALA B 1288 REMARK 465 GLU B 1314 REMARK 465 ALA B 1315 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A1104 OG REMARK 470 LYS A1267 CG CD CE NZ REMARK 470 VAL A1284 CG1 CG2 REMARK 470 ASN A1285 CG OD1 ND2 REMARK 470 GLU B1131 CG CD OE1 OE2 REMARK 470 ARG B1133 CG CD NE CZ NH1 NH2 REMARK 470 ILE B1204 CG1 CG2 CD1 REMARK 470 PHE B1263 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER B1264 OG REMARK 470 THR B1265 OG1 CG2 REMARK 470 LYS B1267 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1565 O HOH A 1598 2.15 REMARK 500 OE2 GLU B 1172 O HOH B 2147 2.15 REMARK 500 O HOH B 2124 O HOH B 2129 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A1263 36.73 -97.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A1234 SG REMARK 620 2 HIS A1237 ND1 107.7 REMARK 620 3 CYS A1242 SG 111.0 110.6 REMARK 620 4 CYS A1245 SG 113.8 104.8 108.7 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B2000 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B1234 SG REMARK 620 2 HIS B1237 ND1 107.7 REMARK 620 3 CYS B1242 SG 112.2 109.2 REMARK 620 4 CYS B1245 SG 114.0 101.7 111.3 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 355 A 1402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN B 2000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4TOR RELATED DB: PDB REMARK 900 4TOR CONTAINS THE SAME PROTEIN DBREF 4TOS A 1105 1315 UNP O95271 TNKS1_HUMAN 1105 1315 DBREF 4TOS B 1105 1315 UNP O95271 TNKS1_HUMAN 1105 1315 SEQADV 4TOS MET A 1080 UNP O95271 INITIATING METHIONINE SEQADV 4TOS GLY A 1081 UNP O95271 EXPRESSION TAG SEQADV 4TOS SER A 1082 UNP O95271 EXPRESSION TAG SEQADV 4TOS SER A 1083 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS A 1084 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS A 1085 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS A 1086 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS A 1087 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS A 1088 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS A 1089 UNP O95271 EXPRESSION TAG SEQADV 4TOS SER A 1090 UNP O95271 EXPRESSION TAG SEQADV 4TOS SER A 1091 UNP O95271 EXPRESSION TAG SEQADV 4TOS GLY A 1092 UNP O95271 EXPRESSION TAG SEQADV 4TOS LEU A 1093 UNP O95271 EXPRESSION TAG SEQADV 4TOS GLU A 1094 UNP O95271 EXPRESSION TAG SEQADV 4TOS VAL A 1095 UNP O95271 EXPRESSION TAG SEQADV 4TOS LEU A 1096 UNP O95271 EXPRESSION TAG SEQADV 4TOS PHE A 1097 UNP O95271 EXPRESSION TAG SEQADV 4TOS GLN A 1098 UNP O95271 EXPRESSION TAG SEQADV 4TOS GLY A 1099 UNP O95271 EXPRESSION TAG SEQADV 4TOS PRO A 1100 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS A 1101 UNP O95271 EXPRESSION TAG SEQADV 4TOS MET A 1102 UNP O95271 EXPRESSION TAG SEQADV 4TOS ALA A 1103 UNP O95271 EXPRESSION TAG SEQADV 4TOS SER A 1104 UNP O95271 EXPRESSION TAG SEQADV 4TOS ILE A 1266 UNP O95271 MET 1266 ENGINEERED MUTATION SEQADV 4TOS MET B 1080 UNP O95271 INITIATING METHIONINE SEQADV 4TOS GLY B 1081 UNP O95271 EXPRESSION TAG SEQADV 4TOS SER B 1082 UNP O95271 EXPRESSION TAG SEQADV 4TOS SER B 1083 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS B 1084 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS B 1085 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS B 1086 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS B 1087 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS B 1088 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS B 1089 UNP O95271 EXPRESSION TAG SEQADV 4TOS SER B 1090 UNP O95271 EXPRESSION TAG SEQADV 4TOS SER B 1091 UNP O95271 EXPRESSION TAG SEQADV 4TOS GLY B 1092 UNP O95271 EXPRESSION TAG SEQADV 4TOS LEU B 1093 UNP O95271 EXPRESSION TAG SEQADV 4TOS GLU B 1094 UNP O95271 EXPRESSION TAG SEQADV 4TOS VAL B 1095 UNP O95271 EXPRESSION TAG SEQADV 4TOS LEU B 1096 UNP O95271 EXPRESSION TAG SEQADV 4TOS PHE B 1097 UNP O95271 EXPRESSION TAG SEQADV 4TOS GLN B 1098 UNP O95271 EXPRESSION TAG SEQADV 4TOS GLY B 1099 UNP O95271 EXPRESSION TAG SEQADV 4TOS PRO B 1100 UNP O95271 EXPRESSION TAG SEQADV 4TOS HIS B 1101 UNP O95271 EXPRESSION TAG SEQADV 4TOS MET B 1102 UNP O95271 EXPRESSION TAG SEQADV 4TOS ALA B 1103 UNP O95271 EXPRESSION TAG SEQADV 4TOS SER B 1104 UNP O95271 EXPRESSION TAG SEQADV 4TOS ILE B 1266 UNP O95271 MET 1266 ENGINEERED MUTATION SEQRES 1 A 236 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 236 LEU GLU VAL LEU PHE GLN GLY PRO HIS MET ALA SER GLY SEQRES 3 A 236 THR ILE LEU LEU ASP LEU ALA PRO GLU ASP LYS GLU TYR SEQRES 4 A 236 GLN SER VAL GLU GLU GLU MET GLN SER THR ILE ARG GLU SEQRES 5 A 236 HIS ARG ASP GLY GLY ASN ALA GLY GLY ILE PHE ASN ARG SEQRES 6 A 236 TYR ASN VAL ILE ARG ILE GLN LYS VAL VAL ASN LYS LYS SEQRES 7 A 236 LEU ARG GLU ARG PHE CYS HIS ARG GLN LYS GLU VAL SER SEQRES 8 A 236 GLU GLU ASN HIS ASN HIS HIS ASN GLU ARG MET LEU PHE SEQRES 9 A 236 HIS GLY SER PRO PHE ILE ASN ALA ILE ILE HIS LYS GLY SEQRES 10 A 236 PHE ASP GLU ARG HIS ALA TYR ILE GLY GLY MET PHE GLY SEQRES 11 A 236 ALA GLY ILE TYR PHE ALA GLU ASN SER SER LYS SER ASN SEQRES 12 A 236 GLN TYR VAL TYR GLY ILE GLY GLY GLY THR GLY CYS PRO SEQRES 13 A 236 THR HIS LYS ASP ARG SER CYS TYR ILE CYS HIS ARG GLN SEQRES 14 A 236 MET LEU PHE CYS ARG VAL THR LEU GLY LYS SER PHE LEU SEQRES 15 A 236 GLN PHE SER THR ILE LYS MET ALA HIS ALA PRO PRO GLY SEQRES 16 A 236 HIS HIS SER VAL ILE GLY ARG PRO SER VAL ASN GLY LEU SEQRES 17 A 236 ALA TYR ALA GLU TYR VAL ILE TYR ARG GLY GLU GLN ALA SEQRES 18 A 236 TYR PRO GLU TYR LEU ILE THR TYR GLN ILE MET LYS PRO SEQRES 19 A 236 GLU ALA SEQRES 1 B 236 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 236 LEU GLU VAL LEU PHE GLN GLY PRO HIS MET ALA SER GLY SEQRES 3 B 236 THR ILE LEU LEU ASP LEU ALA PRO GLU ASP LYS GLU TYR SEQRES 4 B 236 GLN SER VAL GLU GLU GLU MET GLN SER THR ILE ARG GLU SEQRES 5 B 236 HIS ARG ASP GLY GLY ASN ALA GLY GLY ILE PHE ASN ARG SEQRES 6 B 236 TYR ASN VAL ILE ARG ILE GLN LYS VAL VAL ASN LYS LYS SEQRES 7 B 236 LEU ARG GLU ARG PHE CYS HIS ARG GLN LYS GLU VAL SER SEQRES 8 B 236 GLU GLU ASN HIS ASN HIS HIS ASN GLU ARG MET LEU PHE SEQRES 9 B 236 HIS GLY SER PRO PHE ILE ASN ALA ILE ILE HIS LYS GLY SEQRES 10 B 236 PHE ASP GLU ARG HIS ALA TYR ILE GLY GLY MET PHE GLY SEQRES 11 B 236 ALA GLY ILE TYR PHE ALA GLU ASN SER SER LYS SER ASN SEQRES 12 B 236 GLN TYR VAL TYR GLY ILE GLY GLY GLY THR GLY CYS PRO SEQRES 13 B 236 THR HIS LYS ASP ARG SER CYS TYR ILE CYS HIS ARG GLN SEQRES 14 B 236 MET LEU PHE CYS ARG VAL THR LEU GLY LYS SER PHE LEU SEQRES 15 B 236 GLN PHE SER THR ILE LYS MET ALA HIS ALA PRO PRO GLY SEQRES 16 B 236 HIS HIS SER VAL ILE GLY ARG PRO SER VAL ASN GLY LEU SEQRES 17 B 236 ALA TYR ALA GLU TYR VAL ILE TYR ARG GLY GLU GLN ALA SEQRES 18 B 236 TYR PRO GLU TYR LEU ILE THR TYR GLN ILE MET LYS PRO SEQRES 19 B 236 GLU ALA HET ZN A1401 1 HET 355 A1402 42 HET ZN B2000 1 HETNAM ZN ZINC ION HETNAM 355 TRANS-N-BENZYL-4-({1-[(6-METHYL-4-OXO-4H-PYRIDO[1,2- HETNAM 2 355 A]PYRIMIDIN-2-YL)METHYL]-2,4-DIOXO-1,4- HETNAM 3 355 DIHYDROQUINAZOLIN-3(2H)-YL}METHYL) HETNAM 4 355 CYCLOHEXANECARBOXAMIDE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 355 C33 H33 N5 O4 FORMUL 6 HOH *216(H2 O) HELIX 1 AA1 ASP A 1115 THR A 1128 1 14 HELIX 2 AA2 ASN A 1155 ASN A 1173 1 19 HELIX 3 AA3 PHE A 1188 GLY A 1196 1 9 HELIX 4 AA4 ASP A 1198 ARG A 1200 5 3 HELIX 5 AA5 HIS A 1201 GLY A 1206 1 6 HELIX 6 AA6 ASN A 1217 GLN A 1223 1 7 HELIX 7 AA7 GLY A 1227 GLY A 1231 5 5 HELIX 8 AA8 ARG A 1296 GLU A 1298 5 3 HELIX 9 AA9 ASP B 1115 THR B 1128 1 14 HELIX 10 AB1 ASN B 1155 ASN B 1173 1 19 HELIX 11 AB2 PHE B 1188 GLY B 1196 1 9 HELIX 12 AB3 ASP B 1198 ALA B 1202 5 5 HELIX 13 AB4 ASN B 1217 GLN B 1223 1 7 HELIX 14 AB5 GLY B 1227 GLY B 1231 5 5 HELIX 15 AB6 ARG B 1296 GLU B 1298 5 3 SHEET 1 AA1 5 ILE A1107 ASP A1110 0 SHEET 2 AA1 5 TYR A1145 VAL A1154 -1 O VAL A1154 N ILE A1107 SHEET 3 AA1 5 ALA A1300 ILE A1310 -1 O LEU A1305 N GLN A1151 SHEET 4 AA1 5 ARG A1247 THR A1255 -1 N ARG A1247 O TYR A1308 SHEET 5 AA1 5 GLU A1179 HIS A1184 -1 N LEU A1182 O CYS A1252 SHEET 1 AA2 4 ILE A1212 ALA A1215 0 SHEET 2 AA2 4 GLU A1291 ILE A1294 -1 O ILE A1294 N ILE A1212 SHEET 3 AA2 4 SER A1277 GLY A1280 -1 N VAL A1278 O VAL A1293 SHEET 4 AA2 4 SER A1259 GLN A1262 1 N PHE A1260 O ILE A1279 SHEET 1 AA3 5 ILE B1107 ASP B1110 0 SHEET 2 AA3 5 TYR B1145 VAL B1154 -1 O VAL B1154 N ILE B1107 SHEET 3 AA3 5 ALA B1300 ILE B1310 -1 O LEU B1305 N GLN B1151 SHEET 4 AA3 5 ARG B1247 THR B1255 -1 N ARG B1247 O TYR B1308 SHEET 5 AA3 5 GLU B1179 HIS B1184 -1 N LEU B1182 O CYS B1252 SHEET 1 AA4 4 ILE B1212 ALA B1215 0 SHEET 2 AA4 4 GLU B1291 ILE B1294 -1 O TYR B1292 N PHE B1214 SHEET 3 AA4 4 SER B1277 GLY B1280 -1 N GLY B1280 O GLU B1291 SHEET 4 AA4 4 SER B1259 GLN B1262 1 N PHE B1260 O SER B1277 LINK SG CYS A1234 ZN ZN A1401 1555 1555 2.38 LINK ND1 HIS A1237 ZN ZN A1401 1555 1555 1.95 LINK SG CYS A1242 ZN ZN A1401 1555 1555 2.37 LINK SG CYS A1245 ZN ZN A1401 1555 1555 2.30 LINK SG CYS B1234 ZN ZN B2000 1555 1555 2.41 LINK ND1 HIS B1237 ZN ZN B2000 1555 1555 2.01 LINK SG CYS B1242 ZN ZN B2000 1555 1555 2.40 LINK SG CYS B1245 ZN ZN B2000 1555 1555 2.22 SITE 1 AC1 4 CYS A1234 HIS A1237 CYS A1242 CYS A1245 SITE 1 AC2 21 HIS A1184 GLY A1185 SER A1186 PRO A1187 SITE 2 AC2 21 ALA A1191 ILE A1192 LYS A1195 GLY A1196 SITE 3 AC2 21 PHE A1197 ASP A1198 HIS A1201 ALA A1202 SITE 4 AC2 21 GLY A1205 MET A1207 GLY A1211 TYR A1213 SITE 5 AC2 21 LYS A1220 TYR A1224 GLY A1227 HOH A1536 SITE 6 AC2 21 HOH A1605 SITE 1 AC3 4 CYS B1234 HIS B1237 CYS B1242 CYS B1245 CRYST1 48.195 81.168 114.155 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020749 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012320 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008760 0.00000